Startup profile · funding coverage
Bayesian Health
Clinical AI platform for real-time patient risk stratification and triage in hospitals.
Stage
series a
Status
private
Coverage
full
Why Bayesian Health is interesting
Johns Hopkins spinout led by Suchi Saria; peer-reviewed outcomes show faster sepsis detection with high clinician adoption — rare evidence bar for inpatient AI.
Key facts
- Series A (Jul 2021): $15M led by a16z Bio + Health (a16z announcement)
- Co-investors not in VCT directory: Health2047 Capital Partners, Lifeforce Capital, Catalio Capital Management
- Source: https://a16z.com/announcement/investing-in-bayesian-health/
- VCT directory co-investors: none mapped (non-directory syndicates noted above); reviewed 2026-07-24
Investors in our directory
Funds linked from Bayesian Health's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Biotech & Life Sciences
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Bayesian Health
Funding context and why this company shows up in venture coverage.
Bayesian Health is listed among Andreessen Horowitz (a16z) investments on a16z’s public investment list.
We track a16z-backed companies that are strategically relevant for founders and investors following AI, American Dynamism, crypto, bio, and enterprise software.
Last updated: 2026-07-24